Substantial reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials
Publication
, Conference
Young, J; Swedberg, K; Dunlap, ME; Granger, CB; McMurray, JJV; Probstfield, JL; Yusuf, S; Pfeffer, M
Published in: EUROPEAN HEART JOURNAL
August 1, 2004
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
August 1, 2004
Volume
25
Start / End Page
487 / 487
Location
Munich, GERMANY
Publisher
W B SAUNDERS CO LTD
Conference Name
ESC Congress 2004
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Young, J., Swedberg, K., Dunlap, M. E., Granger, C. B., McMurray, J. J. V., Probstfield, J. L., … Pfeffer, M. (2004). Substantial reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials. In EUROPEAN HEART JOURNAL (Vol. 25, pp. 487–487). Munich, GERMANY: W B SAUNDERS CO LTD.
Young, J., K. Swedberg, M. E. Dunlap, C. B. Granger, J. J. V. McMurray, J. L. Probstfield, S. Yusuf, and M. Pfeffer. “Substantial reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials.” In EUROPEAN HEART JOURNAL, 25:487–487. W B SAUNDERS CO LTD, 2004.
Young J, Swedberg K, Dunlap ME, Granger CB, McMurray JJV, Probstfield JL, et al. Substantial reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials. In: EUROPEAN HEART JOURNAL. W B SAUNDERS CO LTD; 2004. p. 487–487.
Young, J., et al. “Substantial reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials.” EUROPEAN HEART JOURNAL, vol. 25, W B SAUNDERS CO LTD, 2004, pp. 487–487.
Young J, Swedberg K, Dunlap ME, Granger CB, McMurray JJV, Probstfield JL, Yusuf S, Pfeffer M. Substantial reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials. EUROPEAN HEART JOURNAL. W B SAUNDERS CO LTD; 2004. p. 487–487.
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
August 1, 2004
Volume
25
Start / End Page
487 / 487
Location
Munich, GERMANY
Publisher
W B SAUNDERS CO LTD
Conference Name
ESC Congress 2004
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology